NCAPD2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.383600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.024200E-01
Normal-vs-Stage2
9.790200E-01
Normal-vs-Stage3
3.036400E-01
Normal-vs-Stage4
7.411800E-01
Stage1-vs-Stage2
1.097230E-01
Stage1-vs-Stage3
4.586000E-01
Stage1-vs-Stage4
5.782200E-01
Stage2-vs-Stage3
2.931000E-01
Stage2-vs-Stage4
7.529800E-01
Stage3-vs-Stage4
3.332200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.790600E-01
Normal-vs-AfricanAmerican
4.688400E-01
Normal-vs-Asian
3.435400E-01
Caucasian-vs-AfricanAmerican
1.280840E-01
Caucasian-vs-Asian
7.186000E-02
AfricanAmerican-vs-Asian
6.800200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.557000E-01
Normal-vs-Female
9.197800E-01
Male-vs-Female
9.035400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.517200E-01
Normal-vs-Age(41-60Yrs)
8.951000E-01
Normal-vs-Age(61-80Yrs)
8.426800E-01
Normal-vs-Age(81-100Yrs)
8.986800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.363800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.859200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.403000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.428000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.983800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.236000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.137400E-01
Normal-vs-Daily Drinker
2.681000E-01
Normal-vs-Weekly Drinker
7.530400E-01
Normal-vs-Occasional Drinker
8.351400E-01
Normal-vs-Social Drinker
7.579400E-01
Non Drinker-vs-Daily Drinker
1.527590E-01
Non Drinker-vs-Weekly Drinker
4.796800E-01
Non Drinker-vs-Occasional Drinker
9.966200E-01
Non Drinker-vs-Social Drinker
6.677800E-01
Daily Drinker-vs-Weekly Drinker
3.267600E-01
Daily Drinker-vs-Occasional Drinker
3.812000E-02
Daily Drinker-vs-Social Drinker
1.610960E-01
Weekly Drinker-vs-Occasional Drinker
3.589000E-01
Weekly Drinker-vs-Social Drinker
3.431000E-01
Occasional Drinker-vs-Social Drinker
6.460000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.557800E-01
Normal-vs-Grade 2
7.492800E-01
Normal-vs-Grade 3
5.418800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.579800E-01
Grade 1-vs-Grade 3
1.630440E-01
Grade 1-vs-Grade 4
8.557800E-01
Grade 2-vs-Grade 3
1.126820E-01
Grade 2-vs-Grade 4
7.492800E-01
Grade 3-vs-Grade 4
5.418800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.084800E-01
Normal-vs-NonDiabetic
8.611200E-01
Diabetic-vs-NonDiabetic
9.849200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.130400E-01
Normal-vs-NoPancreatitis
8.244400E-01
Pancreatitis-vs-NoPancreatitis
4.924400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.983200E-01
Normal-vs-N1
9.136400E-01
N0-vs-N1
8.061000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.436600E-01
Normal-vs-TP53-NonMutant
9.627400E-01
TP53-Mutant-vs-TP53-NonMutant
2.112400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
